Medical News

RSS

Prenatal exposure to some flame retardants associated with attention problems in children

Prenatal exposure to some flame retardants that have been widely-used in consumer products is associated with attention problems in children ages three through seven, according to a new study by researchers at the Columbia Center for Children's Environmental Health, within Columbia's Mailman School of Public Health.

8 Oct 2015

Closure of women's health clinics due to government cuts affects preventive care

When women's health clinics close because of government funding cuts aimed at abortion providers, fewer women seek lifesaving preventive care that can identify health threats such as cancer, research from the University of Kansas shows.

8 Oct 2015

Skin cancer rates higher among gay and bisexual men, UCSF-led study finds

Gay and bisexual men were up to six times more likely than heterosexual men to take part in indoor tanning, and twice as likely to report a history of skin cancer, including nonmelanoma and melanoma, according to a study led by UC San Francisco researchers.

8 Oct 2015

Scientists identify culprit genes behind the formation and progression of breast tumours

A team from the SingHealth Duke-NUS Academic Medical Centre, comprising scientists and clinicians from the National Cancer Centre Singapore, Singapore General Hospital and Duke-NUS Graduate Medical School, has uncovered the genetic landscape of a distinct breast tumour group called fibroepithelial tumours.

8 Oct 2015

Advanced pneumatic compression device reduces cellulitis episodes, saves money for lymphedema patients

Lymphedema patients saw a nearly 80 percent reduction in their cellulitis episodes just by using an advanced pneumatic compression device at home, according to a study in JAMA Dermatology co-authored by Vanderbilt University School of Nursing Professor Sheila Ridner, PhD, MSHSA, FAAN, and University of Minnesota School of Public Health Associate Professor Pinar Karaca-Mandic, PhD.

8 Oct 2015

CAMH study: More than half of workers with depression do not perceive a need for treatment

More than half of workers who reported symptoms of depression did not perceive a need for treatment, according to a study from the Centre for Addiction and Mental Health (CAMH) in Toronto.

8 Oct 2015

High levels of satiety hormone leptin contribute to cardiovascular disease in obese individuals

While high levels of the satiety hormone leptin don't help obese individuals lose weight, they do appear to directly contribute to their cardiovascular disease, researchers report.

8 Oct 2015

Head injury patients do not benefit from brain cooling therapy

Head injury patients do not benefit from a therapy that involves cooling their bodies to reduce brain swelling, research has found.

8 Oct 2015

SMC5/6 protein complex plays vital role in cancer suppression and premature ageing

A study conducted by the Spanish National Cancer Research Centre´s Genomic Instability Group, led by Óscar Fernández-Capetillo, describes for the first time in mammals, the role played by the SMC5/6 protein complex in cancer suppression and premature ageing. Mutations in these complexes, which were sensitive to chemotherapeutic agents, had been previously described in yeast cells, but their exact relationship with cancer or other diseases in mammals was unknown.

8 Oct 2015

New microscope technology may help surgeons work with greater accuracy

Researchers at the University of Arizona have developed a prototype of a new microscope technology that could help surgeons work with a greater degree of accuracy. The new technology, call augmented microscopy, overlays images depicting diagnostic information such as blood flow and cancerous tissue over real images of blood vessels and other tissues and structures being viewed in the microscope.

8 Oct 2015

Smoking cessation medication 46% effective in women

The most effective prescription drug used to quit smoking initially helps women more than men, according to a Yale School of Medicine study. The study, published Oct. 7 by the journal Nicotine and Tobacco Research, found that varenicline, marketed as Chantix, was more effective earlier in women, and equally effective in women and men after one year.

8 Oct 2015

Claritas Genomics announces launch of Claritas Clinical Exome, novel diagnostic test

Claritas Genomics, Inc., announced the launch of its Claritas Clinical Exome, at the Annual Meeting of the American Society of Human Genetics running 10/6 – 10/10 in Baltimore, MD. This novel diagnostic test is the first to exploit the strengths of multiple DNA sequencing platforms simultaneously to deliver confirmed results for a patient’s clinical whole exome within 4 weeks, compared to the industry standard of 12 weeks or more. Patients with rare disease typically seek a diagnosis for 8-12 years, receiving 3-5 separate tests at a high cost.

7 Oct 2015

Genocea announces positive data in Phase 2 trial evaluating GEN-003 for the treatment of genital herpes

Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, has announced positive results from a planned interim analysis of data collected six months after dosing from its ongoing Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. At its best performing dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant, GEN-003 demonstrated a statistically significant 58 percent reduction from baseline in the viral shedding rate (p < 0.0001), the primary endpoint of the study.

7 Oct 2015

Myriad Genetics and Tufts Health Plan sign agreement to cover Prolaris® for members with localized prostate cancer

Myriad Genetics, Inc. (NASDAQ: MYGN) has announced that it has signed a three-year contract with Tufts Health Plan through which the plan will provide coverage of Prolaris® for members diagnosed with localized prostate cancer. Prolaris is the first and only biopsy test validated against prostate cancer specific mortality.

7 Oct 2015

Invitae announces dramatic expansion of genetic testing menu

Invitae Corporation (NYSE: NVTA), a genetic information company, has announced that it has more than doubled the size of its genetic testing platform to include more than 600 genes and will begin releasing the new content between now and the end of the year. Invitae is immediately expanding its menu with dozens of new test panels for hereditary cancer, cardiovascular, neuromuscular, pediatric and other rare disorders.

7 Oct 2015

New white paper on active-ULD performance from CSafe Global

CSafe Global, the world's largest producer of actively controlled mobile refrigeration units for biopharmaceutical and healthcare applications, has released a white paper highlighting the problems and risk associated with using poorly maintained container stock.

7 Oct 2015

Interim data from long-term extension Tecfidera® (dimethyl fumarate) study

Biogen (NASDAQ: BIIB) will, this week, present data at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Barcelona, Spain, demonstrating the efficacy and safety of TECFIDERA® (dimethyl fumarate) across a broad range of people with relapsing-remitting multiple sclerosis (RRMS).

7 Oct 2015

Primasil innovation helps improve Paxman™ cooling cap

Collaboration between Primasil Silicones and its academic partner University of Huddersfield has enabled Paxman™ to bring relief to cancer patients undergoing chemotherapy by further reducing the risk of hair-loss during treatment.

From Paxman 7 Oct 2015

UL study finds Irish mothers struggle to recognise overweight or obesity in their children

A University of Limerick study has found that mothers of overweight and obese children struggle to recognize their child as overweight or obese. The study reported on 7,655 mothers and their nine year old children using data from the national longitudinal study of children, Growing Up in Ireland.

7 Oct 2015

Cell Therapy Catapult launches Cell History File

The Cell Therapy Catapult, the organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the availability of the Cell History File (CHF) template document. The Cell History File template has been developed in conjunction with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), the Human Tissue Authority (HTA) and other cell therapy developers and manufacturers from academia and industry.

7 Oct 2015

Medical News

Prenatal exposure to some flame retardants associated with attention problems in children

Closure of women's health clinics due to government cuts affects preventive care

Skin cancer rates higher among gay and bisexual men, UCSF-led study finds

Scientists identify culprit genes behind the formation and progression of breast tumours

Advanced pneumatic compression device reduces cellulitis episodes, saves money for lymphedema patients

CAMH study: More than half of workers with depression do not perceive a need for treatment

High levels of satiety hormone leptin contribute to cardiovascular disease in obese individuals

Head injury patients do not benefit from brain cooling therapy

SMC5/6 protein complex plays vital role in cancer suppression and premature ageing

New microscope technology may help surgeons work with greater accuracy

Smoking cessation medication 46% effective in women

Claritas Genomics announces launch of Claritas Clinical Exome, novel diagnostic test

Genocea announces positive data in Phase 2 trial evaluating GEN-003 for the treatment of genital herpes

Myriad Genetics and Tufts Health Plan sign agreement to cover Prolaris® for members with localized prostate cancer

Invitae announces dramatic expansion of genetic testing menu

New white paper on active-ULD performance from CSafe Global

Interim data from long-term extension Tecfidera® (dimethyl fumarate) study

Primasil innovation helps improve Paxman™ cooling cap

UL study finds Irish mothers struggle to recognise overweight or obesity in their children

Cell Therapy Catapult launches Cell History File

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News